Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 1 (January)

1. Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial.
   Br J Psychiatry, 196(1): 59-63. [Abstract] [Full-text]
2. White matter microstructural abnormalities in euthymic bipolar disorder.
   Br J Psychiatry, 196(1): 52-8. [Abstract] [Full-text]
3. Brain serotonin-2 receptors in acute mania.
   Br J Psychiatry, 196(1): 47-51. [Abstract] [Full-text]
4. Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data.
   Am J Health Syst Pharm, 67(1): 27-37. [Abstract] [Full-text]
5. Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.
   Ann Gen Psychiatry, 8(1): 27. [Abstract] [Full-text]
6. Differential engagement of cognitive and affective neural systems in pediatric bipolar disorder and attention deficit hyperactivity disorder.
   J Int Neuropsychol Soc, 16(1): 106-17. [Abstract] [Full-text]
7. Phenotyping of an in vitro model of ischemic penumbra by iTRAQ-based shotgun quantitative proteomics.
   J Proteome Res, 9(1): 472-84. [Abstract] [Full-text]
8. On the Role of Goal Dysregulation in the Treatment of Bipolar Disorder.
   Clin Psychol (New York), 16(4): 470-475. [Abstract] [Full-text]
9. Enhancing medication adherence in patients with bipolar disorder.
   Hum Psychopharmacol, 25(1): 1-16. [Abstract] [Full-text]
10. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.
    Hum Psychopharmacol, 25(1): 47-54. [Abstract] [Full-text]
11. Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial.
    Hum Psychopharmacol, 25(1): 30-6. [Abstract] [Full-text]
12. Expanding the range of ZNF804A variants conferring risk of psychosis.
    Mol Psychiatry. [Abstract] [Full-text]
13. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Arch Gen Psychiatry, 67(1): 26-36. [Abstract] [Full-text]
14. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on bipolar depression.
    Harv Rev Psychiatry, 18(1): 36-55. [Abstract] [Full-text]
15. Exercise Treatment for Bipolar Disorder: Potential Mechanisms of Action Mediated through Increased Neurogenesis and Decreased Allostatic Load.
    Psychother Psychosom, 79(2): 87-96. [Abstract] [Full-text]
16. No Effect of Parental Age on Risk of Multiple Sclerosis: A Population-Based Study.
    Neuroepidemiology, 34(2): 106-109. [Abstract] [Full-text]
17. Effects of discontinuing benzodiazepine-derivative hypnotics on postural sway and cognitive functions in the elderly.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
18. Increased right amygdala volume in lithium-treated patients with bipolar I disorder.
    Acta Psychiatr Scand, 121(2): 119-24. [Abstract] [Full-text]
19. Subthreshold conditions as precursors for full syndrome disorders: a 15-year longitudinal study of multiple diagnostic classes.
    J Child Psychol Psychiatry, 50(12): 1485-94. [Abstract] [Full-text]
20. Berkson's bias and the mood dimensions of bipolar disorder.
    Int J Methods Psychiatr Res, 18(4): 279-86. [Abstract] [Full-text]
21. Racial/Ethnic group differences in bipolar symptomatology in a community sample of persons with bipolar I disorder.
    J Nerv Ment Dis, 198(1): 16-21. [Abstract] [Full-text]
22. Evidence that bipolar disorder is the poor outcome fraction of a common developmental phenotype: an 8-year cohort study in young people.
    Psychol Med, 40(2): 289-99. [Abstract] [Full-text]
23. Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant?
    Psychol Med, 40(2): 201-10. [Abstract] [Full-text]
24. Lamotrigine: an unusual etiology for aseptic meningitis.
    Neurologist, 16(1): 35-6. [Abstract] [Full-text]
25. Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder.
    Am J Psychiatry, 167(1): 61-9. [Abstract] [Full-text]
26. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations.
    Am J Psychiatry, 167(1): 78-85. [Abstract] [Full-text]
27. A Naturalistic Exploratory Study of the Impact of Demographic, Phenotypic and Comorbid Features in Pediatric Obsessive-Compulsive Disorder.
    Psychopathology, 43(2): 69-78. [Abstract] [Full-text]
28. Neurological and cardiovascular adverse events associated with antimanic treatment in children and adolescents.
    CNS Neurosci Ther, 16(1): 25-31. [Abstract] [Full-text]
29. Motor function may differentiate attention deficit hyperactivity disorder from early onset bipolar disorder.
    Behav Brain Funct, 5: 47. [Abstract] [Full-text]
30. Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis.
    J Clin Psychopharmacol, 30(1): 72-5. [Abstract] [Full-text]
31. Tourette syndrome: information for school nurses.
    J Sch Nurs, 26(1): 11-7. [Abstract] [Full-text]
32. Does age at onset have clinical significance in older adults with bipolar disorder?
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
33. Who rules the roost?
    J Dev Behav Pediatr, 31(1): 72-4. [Abstract] [Full-text]
34. Perturbed reward processing in pediatric bipolar disorder: an antisaccade study.
    J Psychopharmacol. [Abstract] [Full-text]
35. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Int J Neuropsychopharmacol, 13(1): 5-14. [Abstract] [Full-text]
36. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
    Psychopharmacology (Berl), 208(3): 443-54. [Abstract] [Full-text]
37. Effect of mood stabilizers on gene expression in lymphoblastoid cells.
    J Neural Transm, 117(2): 155-64. [Abstract] [Full-text]
38. Mood disorders and quality of life. A community study.
    Nord J Psychiatry, 64(1): 58-62. [Abstract] [Full-text]
39. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
    Neuroimmunomodulation, 17(2): 126-31. [Abstract] [Full-text]
40. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase.
    Mol Psychiatry, 15(2): 216-25. [Abstract] [Full-text]
41. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
    Clin Toxicol (Phila), 48(1): 34-41. [Abstract] [Full-text]
42. WITHDRAWN: Common polymorphisms in the MDGA1 gene are associated with bipolar disorder and schizophrenia in the Chinese Han population.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
43. Mania possibly induced by desvenlafaxine.
    J Psychiatr Pract, 16(1): 58-62. [Abstract] [Full-text]
44. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines.
    J Psychiatr Pract, 16(1): 34-45. [Abstract] [Full-text]
45. Functional SNPs in Genes Encoding the 5-HT2A Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic Drugs.
    Biol Res Nurs. [Abstract] [Full-text]
46. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.
    Mol Psychiatry, 15(2): 146-53. [Abstract] [Full-text]
47. Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain.
    J Neural Transm, 117(2): 149-53. [Abstract] [Full-text]
48. Acute pancreatitis associated with lisinopril and olanzapine.
    Am J Health Syst Pharm, 67(3): 214-6. [Abstract] [Full-text]
49. Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders.
    Biol Psychiatry, 67(3): 270-4. [Abstract] [Full-text]
50. Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia.
    Biol Psychiatry, 67(3): 217-23. [Abstract] [Full-text]
51. Porcine proximal tubular cells (LLC-PK1) are able to tolerate high levels of lithium chloride in vitro: assessment of the influence of 1-20 mM LiCl on cell death and alterations in cell biology and biochemistry.
    Cell Biol Int, 34(2): 225-33. [Abstract] [Full-text]
52. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.
    Nat Genet, 42(2): 128-31. [Abstract] [Full-text]
53. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Ther Drug Monit, 32(1): 19-29. [Abstract] [Full-text]
54. Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
    J Psychiatr Res, 44(1): 8-14. [Abstract] [Full-text]
55. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
    Ther Drug Monit, 32(1): 107-11. [Abstract] [Full-text]
56. Paternal and maternal ages at conception and risk of bipolar affective disorder in their offspring.
    Psychol Med, 40(3): 477-85. [Abstract] [Full-text]
57. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Neuropsychopharmacology, 35(3): 727-40. [Abstract] [Full-text]
58. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.
    Neuropsychopharmacology, 35(3): 834-46. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.